Fawwad Qureshi Sells 622 Shares of Trupanion, Inc. (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 622 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares of the company’s stock, valued at $519,102.87. This represents a 5.93 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Trupanion Trading Down 1.6 %

Trupanion stock opened at $53.50 on Thursday. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The stock has a market capitalization of $2.27 billion, a PE ratio of -167.19 and a beta of 1.69. The firm has a 50 day simple moving average of $49.50 and a 200-day simple moving average of $39.97. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter in the previous year, the company earned ($0.10) earnings per share. The firm’s quarterly revenue was up 14.6% compared to the same quarter last year. As a group, equities research analysts expect that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on TRUP. Piper Sandler boosted their price target on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Stifel Nicolaus boosted their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and an average price target of $44.67.

Institutional Investors Weigh In On Trupanion

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TRUP. State Board of Administration of Florida Retirement System raised its holdings in Trupanion by 12.6% during the first quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider’s stock worth $351,000 after purchasing an additional 1,420 shares in the last quarter. Vanguard Group Inc. raised its holdings in Trupanion by 0.9% during the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after purchasing an additional 32,485 shares in the last quarter. CANADA LIFE ASSURANCE Co raised its holdings in Trupanion by 2.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock worth $1,188,000 after purchasing an additional 830 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Trupanion by 14.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider’s stock valued at $313,000 after buying an additional 1,441 shares in the last quarter. Finally, Bayesian Capital Management LP bought a new position in shares of Trupanion in the first quarter valued at $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.